Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Brompheniramine Maleate 12 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to treat symptoms of allergic rhinitis, urticaria, pruritus, asthma, and bronchitis. The slow release mechanism reduces dosing frequency and improves patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Brompheniramine Maleate 12 mg Slow Release Capsules is a compounded medication primarily used to alleviate symptoms associated with allergies, colds, and hay fever. As an antihistamine, it functions by inhibiting the action of histamine, a substance in the body that triggers allergic symptoms. This particular formulation is engineered with Methocel E4M, a controlled-release polymer, to ensure a gradual and sustained release of the active ingredient over an extended period. This slow-release mechanism allows for more consistent symptom relief and reduces the frequency of dosing, thereby improving patient compliance.
This medication can be utilized to manage a range of conditions, including allergic rhinitis, urticaria, pruritus, as well as colds, hay fever, and other upper respiratory tract infections. The slow-release formulation is designed to provide long-lasting relief from symptoms, enabling patients to carry on with their daily activities with minimal disruption.
When taking Brompheniramine Maleate 12 mg Slow Release Capsules, it is crucial for patients to adhere to the instructions provided by their healthcare provider. Awareness of potential side effects such as drowsiness, dry mouth, and dizziness is also important. Additionally, patients should be mindful of potential drug interactions, as Brompheniramine Maleate 12 mg Slow Release Capsules may interact with other medications.
For healthcare providers considering prescribing Brompheniramine Maleate 12 mg Slow Release Capsules, it is essential to take into account the patient's medical history and any other medications they may be currently taking. The potential side effects and drug interactions associated with this formulation should also be considered.
If you have any queries regarding Brompheniramine Maleate 12 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is equipped with the knowledge and expertise to assist you.
Brompheniramine Maleate 12 mg Slow Release Capsules are a specialized formulation designed for the treatment of various allergic conditions such as allergic rhinitis, urticaria, and other allergies. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
It's important for patients to be aware that Brompheniramine Maleate 12 mg Slow Release Capsules may interact with other medications, including anticholinergics, antihistamines, and decongestants. Therefore, patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. This is to avoid potential drug interactions that may increase the risk of side effects.
Patients should not take Brompheniramine Maleate 12 mg Slow Release Capsules if they are currently on monoamine oxidase inhibitors (MAOIs) or have taken them within the past 14 days. Alcohol should also be avoided while taking these capsules, as it may increase the risk of side effects. Furthermore, patients should be aware that Brompheniramine Maleate 12 mg Slow Release Capsules may cause drowsiness. As such, they should refrain from driving or operating machinery until they fully understand how the medication affects them.
Brompheniramine Maleate 12 mg Slow Release Capsules are a potent medication designed to alleviate symptoms associated with allergies, colds, and hay fever. The unique slow-release formulation, made possible by the use of Methocel E4M, a controlled-release polymer, ensures a gradual release of the medication. This results in sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
These capsules are administered orally, typically once or twice a day, as per the doctor's prescription. It is crucial to adhere to the prescribed dosage and not exceed it. To minimize the risk of stomach upset, it is recommended to take the medication with food or milk.
Additionally, they can be employed to manage nausea, vomiting, and motion sickness.
If you have any queries regarding Brompheniramine Maleate 12 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is always ready to assist you.
Brompheniramine Maleate 12 mg Slow Release Capsules are a versatile medication, designed to provide sustained relief from a variety of symptoms. These capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow release mechanism offers prolonged therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance, particularly for medications requiring a controlled and extended release profile.
These capsules can be used to treat a wide range of conditions and symptoms. They can also alleviate symptoms of the common cold, such as sneezing, runny nose, and itchy eyes. In addition, they can be used to manage motion sickness, nausea, and vomiting.
Brompheniramine Maleate 12 mg Slow Release Capsules are also beneficial for those suffering from hay fever, providing relief from symptoms such as sneezing, runny nose, and itchy eyes. They can also be used to manage symptoms of allergic reactions to certain medications, including rash, itching, and hives. Similarly, they can be used to treat symptoms of allergic reactions to certain foods, such as rash, itching, and hives.
If you have any questions about the uses of Brompheniramine Maleate 12 mg Slow Release Capsules, please do not hesitate to reach out for more information.
Brompheniramine Maleate 12 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is used in the formulation to ensure that the medication is released gradually over a prolonged period, offering sustained therapeutic effects.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
Due to the slow release formulation, the frequency of dosing is reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific condition and response to therapy.
Improved patient compliance means that patients are more likely to take the medication as prescribed. This is often due to reduced dosing frequency and sustained therapeutic effects, which can make the treatment regimen easier to follow.
No, the slow release formulation does not affect the effectiveness of the medication. In fact, it enhances the therapeutic effects by ensuring a steady release of the medication over an extended period of time.
No, the capsule should not be opened, crushed, or chewed. Doing so can release all of the drug at once, increasing the risk of side effects. The capsule should be swallowed whole.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Before starting any new medication, it is important to discuss with your healthcare provider. Some medications may interact with Brompheniramine Maleate 12 mg Slow Release Capsules, affecting how it works or increasing the risk of side effects.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Symptoms of overdose may include severe drowsiness, seizures, and widened pupils. Do not induce vomiting unless told to do so by a healthcare professional.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
